|
Match
|
Document |
Document Title |
|
|
7585520 |
Compositions containing both sedative and non-sedative antihistamines and sleep aids
Compositions containing both a sedative compound and a non-sedative antihistamine are provided. More particularly, compositions for administration at bedtime containing a sedating antihistamine or...
|
|
|
7553500 |
Pharmaceutical composition having uniform drug distribution and potency
Pharmaceutical compositions having uniform drug distribution and potency utilizing laxofoxifene as an active ingredient and containing a silicon dioxide to reduce loss of the active ingredient...
|
|
|
7550158 |
Controlled release by extrusion of solid amorphous dispersions of drugs
Controlled release dosage forms for low solubility drugs are disclosed wherein an amorphous solid dispersion of the drug is coated with a non-dissolving and non-eroding coating that controls the...
|
|
|
7547474 |
Lubricious coatings for pharmaceutical applications
The invention provides pills and tablets having lubricious coating deposited over the outer surface of the pills and the tablets.
|
|
|
7547451 |
Pellet formulation for the treatment of the intestinal tract
An orally adminsterable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a...
|
|
|
7541347 |
Minocycline oral dosage forms for the treatment of acne
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
|
|
|
7537784 |
Modified release tablet of bupropion hydrochloride
A modified-release tablet of bupropion hydrochloride comprising (i) a core comprising an effective amount of bupropion hydrochloride, a binder, a lubricant; and (ii) a control releasing coat...
|
|
|
7514100 |
Controlled release hydrocodone formulations
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof,...
|
|
|
7510729 |
Combination of polyvinyl acetate with water-insoluble, acid-insoluble, or alkali-insoluble polymers used for the production of film coatings with highly controlled release and high stability
The invention relates to the combination of polyvinyl acetate and water-insoluble, acid-insoluble, or alkali-insoluble polymers used for producing film coatings for forms of administration in which...
|
|
|
7510728 |
Solid preparations
In a solid pharmaceutical preparation containing 1) a basic medicinal component having an unpleasant taste; 2) a saccharide; 3) a polyanionic polymer; 4) a corrigent; and 5) carboxymethylcellulose,...
|
|
|
7470435 |
Extended release venlafaxine formulation
A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
|
|
|
7435715 |
Microcapsules
Microcapsules for use in liquid detergents having a core and a polyelectrolyte complex shell in the form of a semipermeable membrane capable of withstanding a force before bursting of from about 20...
|
|
|
7431944 |
Delivery of multiple doses of medications
Dosage forms for oral administration of a methylphenidate drug are provided. The dosage forms provide a substantially immediate dose of methylphenidate upon ingestion, followed by one or more...
|
|
|
7431943 |
Controlled release and taste masking oral pharmaceutical compositions
Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic,...
|
|
|
7416738 |
Modified release dosage form
A modified release dosage form comprising at least one active ingredient and at least two cores surrounded by a shell is provided. The shell comprises at least one opening and provides for modified...
|
|
|
7404970 |
Pain relief composition, method to form same, and method to use same
An oral dosage form which includes a bi-layer tablet consisting of an Actives Granulation layer and an Osmagen Granulation layer is disclosed. An encapsulant is disposed over that bi-layer tablet....
|
|
|
7387791 |
Liposome drug delivery
This invention comprises pharmaceutical compositions for administering a biologically active compound to an animal. Particularly provided are proliposomal compositions that are advantageously used...
|
|
|
7357946 |
Uses for cellulose-containing aggregates
Aggregates of cellulose-containing particles, such as particles of waste paper and optional other vegetation or waste particles are used as a carrier for additives such as insecticides, herbicides,...
|
|
|
7357945 |
Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
Provided are formulations of a stable paroxetine hydrochloride tablet comprising paroxetine hydrochloride, povidone or copovidone as a binder, and an HCl free/non-hygroscopic filler, prepared by...
|
|
|
7351429 |
Oral solid preparation
The invention is to provide an oral solid pharmaceutical that is uniform in the content of KRP-197, having bladder-selective anticholinergic activity, being a therapeutic drug for pollakiuria and...
|
|
|
7316818 |
Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
This invention comprises pharmaceutical compositions for administering a polycyclic, aromatic, antioxidant or anti-inflammatory compound to an animal. Particularly provided are proliposomal...
|
|
|
7303763 |
Compositions for conjugated estrogens and associated methods
Oral conjugated estrogen formulations are disclosed and described. In one aspect, the oral formulation may be a tablet having a core and one or more coatings thereon. In addition to conjugated...
|
|
|
7276253 |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
The invention relates to a stable medicament for oral administration which comprises
(a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole,...
|
|
|
7276252 |
Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form
A drug delivery device such as an oral dosage form (ODF) with a toxic or potent core encapsulated by a non-toxic region. The non-toxic region may be a region including multiple layers, coatings,...
|
|
|
7270831 |
Orally administrable opioid formulations having extended duration of effect
Sustained release oral solid dosage forms of opioid analgesics are provided as multiparticulate systems which are bioavailable and which provide effective blood levels of the opioid analgesic for...
|
|
|
7258872 |
Chromone enteric release formulation
Orally administered chromones have been found to be effective in the treatment of allergic conditions such as asthma, general food allergies, ulcerative colitis, atopic eczema, chronic urticaria,...
|
|
|
7235253 |
Powder containing physiologically active peptide
A method is disclosed for stabilizing a physiologically active peptide in a process of preparing a powder containing the physiologically active peptide by drying an aqueous liquid containing the...
|
|
|
7229643 |
Oral 2-methyl-thieno-benzodiazepine formulation
The invention provides a pharmaceutically elegant solid oral formulation of olanzapine and a process for making such formulation.
|
|
|
7229640 |
Paroxetine controlled release compositions
A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxtine.
|
|
|
7220430 |
Sustained-release preparation and process for producing the same
The present invention is to provide a sustained release preparation comprising a drug-containing core substance and a multilayered coating layer covering the core substance, wherein all adjacent...
|
|
|
7217431 |
Controlled agglomeration
A process for the preparation of a particulate material by a controlled agglomeration method, i.e. a method that enables a controlled growth in particle size. The method is especially suitable for...
|
|
|
7217429 |
Tableted oral pharmaceutical dosage form, with enteric coating, containing a compound of benzimidazole labile in an acid medium
The pharmaceutical dosage form consists of a plurality of units containing a benzimidazole compound labile in an acid medium as the active principle, each unit being comprised of an inert core, a...
|
|
|
7214387 |
Sustained release formulations of metformin
The invention provides sustained release formulations of metformin or a pharmaceutically acceptable salt thereof, and methods of treating diabetes by administering to a patient a therapeutically...
|
|
|
7202087 |
Anticoagulant composition
A solid heparin tablet composition has a melting point of 25° C. or higher and is a continuous lipid component containing one or more polar lipids, one or more non-polar lipids, optionally one or...
|
|
|
7201922 |
Orodispersible solid pharmaceutical form
The subject of the invention is an orodispersible solid pharmaceutical form characterized in that it comprises:
granules consisting of lactose and starch which have been codried; at least...
|
|
|
7186418 |
Composition and use of RAR antagonists for promoting chondrogenesis
The invention provides compositions comprising an RAR antagonist for promoting chondrogenesis and methods employing such compositions for treating cartilage and associated bone abnormalities...
|
|
|
7179486 |
Process for preparing sustained release tablets
The present invention is directed to the process of preparing a sustained release niacin tablet and the product prepared therefrom.
|
|
|
7169450 |
Enrobed core
An enrobed a core, such as a tablet core, that has a coating made of one or more patterned films each having portions that are visually distinct (e.g., differently colored) from one another and...
|
|
|
7147870 |
Osmotic device containing pseudoephedrine and an H1 antagonist
The present invention provides an osmotic device containing controlled release pseudoephedrine in the core in combination with a rapid release H1 antagonist in an external coat. A wide range of H1...
|
|
|
7144585 |
Cilostazol preparation
Provided is a cilostazol preparation which comprises incorporating a fine powder of cilostazol into a dispersing and/or solubilizing agent thereby to enhance the dispersibility and/or solubility....
|
|
|
7125567 |
Process for producing an oral sustained-release preparation of fasudil hydrochloride
Disclosed is an oral sustained-release preparation which contains at least one active ingredient selected from the group consisting of fasudil hydrochloride and a hydrate thereof, the preparation...
|
|
|
7118762 |
Controlled release lipoic acid
A controlled release formulation of lipoic acid is disclosed. The lipoic acid is combined with excipient materials in such a way that those materials provide for gradual release of the lipoic acid...
|
|
|
7108864 |
Tablet formation
Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the...
|
|
|
7097851 |
Oral formulation for gastrointestinal drug delivery
An oral formulation for gastrointestinal drug delivery which comprises an adhesion site-controlling layer for attaching the formulation to the selected site in the digestive tract, a drug-carrying...
|
|
|
7094427 |
Combination immediate release controlled release levodopa/carbidopa dosage forms
The present invention relates to dosage forms of a combination of carbidopa and levodopa comprising both immediate release and controlled release components for the treatment of ailments associated...
|
|
|
7094426 |
Stable oral pharmaceutical dosage forms
The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such...
|
|
|
7087242 |
Subcoated simulated capsule-like medicament
A simulated capsule-like medicament comprising a subcoating of a mixture of a water-soluble, film-forming polymer, e.g. hydroxypropylmethyl cellulose and a hydrophobic plasticizer, e.g. castor oil,...
|
|
|
7081255 |
Antifungal compositions with improved bioavailability
The present invention is concerned with novel pharmaceutical compositions of itraconazole which can be administered to a mammal suffering from a fungal infection, whereby a single such dosage form...
|
|
|
7074428 |
Quick disintegrating tablet in buccal cavity and manufacturing method thereof
The present invention pertains to a quick disintegrating tablet in buccal cavity, characterized in that drug-containing particles with a mean particle diameter of approximately 50 to approximately...
|
|
|
RE39149 |
Method of administering azithromycin
An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets;...
|